截至发稿，夏高累计任职时间10年354天，现任基金资产总规模24.94亿元，任职期间最佳基金回报 233.78%， 任职期间最差基金回报-71.74%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，大成基金旗下1只基金位居融捷健康十大流通股东。大成中证360互联网+指数A（002236） 三季度新进十大流通股东，持有股数364.93万股，占流通股的比例为0.45%。根据测算，今日浮亏损失 约91.23万元。连续3天下跌期间浮亏损失229.91万元。 大成中证360互联网+指数A（002236）成立日期2016年2月3日，最新规模7.88亿。今年以来收益 38.22%，同类排名871/4208；近一年收益39.52%，同类排名577/3972；成立以来收益226%。 大成中证360互联网+指数A（002236）基金经理为夏高。 11月21日，融捷健康跌5.06%，截至发稿，报4.69元/股，成交1.05亿元，换手率2.72%，总市值37.71亿 元。融捷健康股 ...

Group 1 - The core point of the news is that Rongjie Health's stock price dropped by 5.04% to 5.09 CNY per share, with a trading volume of 232 million CNY and a turnover rate of 5.59%, resulting in a total market capitalization of 4.093 billion CNY [1] - Rongjie Health Technology Co., Ltd. is based in Hefei, Anhui Province, established on April 21, 1995, and listed on July 29, 2011. The company primarily engages in the production and sales of health products, including far-infrared sauna rooms, air purifiers, fitness equipment, massage chairs, and various health-related small products [1] - The revenue composition of Rongjie Health's main business includes 77.30% from far-infrared therapy sauna rooms, 13.66% from other products, 4.91% from portable sauna products, and 4.13% from air purifiers [1] Group 2 - Among the top ten circulating shareholders of Rongjie Health, a fund under Dacheng Fund ranks first. The Dacheng CSI 360 Internet + Index A (002236) entered the top ten circulating shareholders in the third quarter, holding 3.6493 million shares, accounting for 0.45% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A (002236) was established on February 3, 2016, with a latest scale of 788 million CNY. Year-to-date, it has achieved a return of 41.54%, ranking 792 out of 4208 in its category; over the past year, it has returned 50.04%, ranking 442 out of 3956; and since inception, it has returned 233.83% [2]

Group 1 - The core viewpoint of the news is that Rongjie Health has seen a stock price increase of 5.07%, reaching 4.77 CNY per share, with a trading volume of 1.52 billion CNY and a turnover rate of 4.11%, resulting in a total market capitalization of 38.35 billion CNY [1] - Rongjie Health Technology Co., Ltd. is based in Hefei, Anhui Province, established on April 21, 1995, and listed on July 29, 2011. The company primarily focuses on the production and sales of health products, including far-infrared sauna rooms, air purifiers, fitness equipment, massage chairs, and various health-related small products [1] - The main revenue composition of Rongjie Health includes 77.30% from far-infrared therapy sauna rooms, 13.66% from other products, 4.91% from portable sauna products, and 4.13% from air purifiers [1] Group 2 - Among the top ten circulating shareholders of Rongjie Health, a fund under Dacheng Fund ranks first. The Dacheng CSI 360 Internet + Index A (002236) entered the top ten circulating shareholders in the third quarter, holding 3.6493 million shares, which accounts for 0.45% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A (002236) was established on February 3, 2016, with a latest scale of 788 million CNY. Year-to-date returns are 39.53%, ranking 1082 out of 4216 in its category; the one-year return is 35.95%, ranking 596 out of 3937; and since inception, the return is 229.09% [2]

Core Viewpoint - Rongjie Health, established in 1995 and listed in 2011, focuses on health products, particularly far-infrared sauna rooms, and has diversified product offerings [1] Group 1: Business Performance - In Q3 2025, Rongjie Health reported revenue of 652 million yuan, ranking third in the industry, with the leader, Aojiahua, at 3.724 billion yuan [2] - The main product, far-infrared therapeutic sauna rooms, generated 309 million yuan, accounting for 77.3% of total revenue [2] - The net profit for the same period was 91.49 million yuan, ranking second in the industry, with the leader, Rongtai Health, at 111 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Rongjie Health's debt-to-asset ratio was 17.13%, lower than the industry average of 25.55% [3] - The gross profit margin for Q3 2025 was 36.76%, higher than the industry average of 34.44% [3] Group 3: Executive Compensation - The chairman, Xing Fenling, received a salary of 278,600 yuan in 2024, a decrease of 171,900 yuan from 2023 [4] - The general manager, Qian Xiaodong, had a salary of 699,300 yuan in 2024, down by 89,200 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 1.04% to 29,300 [5] - The average number of circulating A-shares held per shareholder increased by 1.05% to 27,400 [5]

Core Viewpoint - Rongjie Health's main supply chain for its U.S. subsidiary is sourced from China, and the company is currently evaluating measures to potentially shift its supply chain [1] Summary by Relevant Sections - **Sales to the U.S.**: In 2024, the company's sales to the U.S. are projected to be $61.985 million, with $5.3234 million coming from domestic factory exports and $56.6615 million from sales made by the U.S. subsidiary [1] - **Product Classification**: The far-infrared sauna rooms sold to the U.S. are classified as wood products and do not qualify for the "reciprocal tariff" exemption [1] - **Supply Chain Assessment**: The company is assessing measures related to the potential transfer of its supply chain [1]